Collective Dose Fallacy

I have spent more than 45 years working in a variety of areas in nuclear science and technology, with a number of them in radiation protection. It was a pleasure to read Theodore Rockwell's article (Opinion, The Scientist, March 3, 1997, page 9). It is high time for the scientific community to look at the data supporting the Linear No-Threshold model (of which there are none) and the data supporting a threshold model (of which there are a great number). Also, the concept of "collective dose" d

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

I have spent more than 45 years working in a variety of areas in nuclear science and technology, with a number of them in radiation protection. It was a pleasure to read Theodore Rockwell's article (Opinion, The Scientist, March 3, 1997, page 9). It is high time for the scientific community to look at the data supporting the Linear No-Threshold model (of which there are none) and the data supporting a threshold model (of which there are a great number).

Also, the concept of "collective dose" does not make any sense when you apply an example like aspirin. That is, a dose of 100 aspirins to one individual will cause that individual's death, but that does not mean that if you give each of 100 people one aspirin, then there will be one death in that group of people.

Thank you for printing Rockwell's article.

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Charles Thomas

    This person does not yet have a bio.

Published In

Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo
New Frontiers in Vaccine Development

New Frontiers in Vaccine Development

Sino

Products

Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide

Inventia Life Science

Inventia Life Science Launches RASTRUM™ Allegro to Revolutionize High-Throughput 3D Cell Culture for Drug Discovery and Disease Research

An illustration of differently shaped viruses.

Detecting Novel Viruses Using a Comprehensive Enrichment Panel

Twist Bio 
Zymo Research

Zymo Research Launches Microbiome Grant to Support Innovation in Microbial Sciences